Per Norlén
Chief Executive Officer at WNTRESEARCH AB
Net worth: - $ as of 2024-04-29
Network origin in Per Norlén first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Lund
85
| College/University | Other Consumer Services | 85 |
| Public Company | Biotechnology | 23 | |
| Public Company | Pharmaceuticals: Other | 11 | |
| Public Company | Biotechnology | 6 | |
| Public Company | Biotechnology | 4 | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Per Norlén via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| CAMURUS AB | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree Director/Board Member Masters Business Admin | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| BPC INSTRUMENTS AB | Electronic Equipment/Instruments | Founder Director/Board Member Founder | |
| SELECTIMMUNE PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| GENOVIS AB | Medical Specialties | Chief Executive Officer President Chairman | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| A Bioscience Incentive AB | Corporate Officer/Principal Director/Board Member Director/Board Member | ||
| University of Gothenburg | College/University | Graduate Degree Masters Business Admin Doctorate Degree | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor Chief Executive Officer Private Equity Investor | |
| IDOGEN AB (PUBL) | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Founder | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Wntresearch Incentive AB | Director/Board Member Director/Board Member Director/Board Member | ||
| HAMLET PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LU Holding AB
 LU Holding AB Investment ManagersFinance LU Holding AB (LU Holding) is a venture capital subsidiary of University of Lund founded in 1994. The firm is headquartered in Lund, Sweden. | Investment Managers | Director/Board Member Director/Board Member | |
QuNano AB
 QuNano AB SemiconductorsElectronic Technology QuNano AB provides nano-sized semiconductor materials and devices. The firm explores and develops novel nano fabrication techniques suited for commercialization and high volume manufacturing, novel concepts and architectures in the arena of nano-electronics. The company was founded by Bjorn Jonas Ohlsson, Lars Ivar Samuelson, Lars-Erik Wernersson and Lars-Ake Ledebo in 2005 and is headquartered in Lund, Sweden. | Semiconductors | Founder Comptroller/Controller/Auditor | |
| University of Uppsala | College/University | Corporate Officer/Principal Graduate Degree | |
| COMBIGENE AB | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| ABLIVA AB | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
| Atherioco AB | Chairman Director/Board Member | ||
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Chief Executive Officer | |
| Preelumina Diagnostics AB | Director/Board Member Founder | ||
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Chairman Founder | |
| STORYTEL AB | Publishing: Books/Magazines | Director/Board Member Director/Board Member | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Corporate Officer/Principal Masters Business Admin | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member Chairman | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| University of California | College/University | Graduate Degree Graduate Degree | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| QLUCORE AB | Packaged Software | Founder Founder | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Investor Relations Contact | |
| GeccoDots AB | Director/Board Member Chairman | ||
| ACUCORT AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Sand Medical AB
 Sand Medical AB Medical/Nursing ServicesHealth Services Sand Medical AB provides medical care services. The private company is based in Stockholm, Sweden. | Medical/Nursing Services | Director/Board Member Chairman | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CMC SPV of 3 April 2017 AB | Director/Board Member Director/Board Member |
Statistics
International
| Sweden | 43 |
| Denmark | 4 |
| United Kingdom | 3 |
| Germany | 2 |
| United States | 2 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 471 |
| Corporate Officer/Principal | 199 |
| Chairman | 101 |
| Independent Dir/Board Member | 69 |
| Founder | 65 |
Most connected contacts
- Stock Market
- Insiders
- Per Norlén
- Company connections
